Metabolomics, Lipid Pathways, and Blood Pressure Change.
作者信息
Arnett Donna K, Graf Gregory A
机构信息
From the College of Public Health (D.K.A.), University of Kentucky, Lexington.
Department of Pharmaceutical Sciences (G.A.G.), University of Kentucky, Lexington.
出版信息
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1801-1803. doi: 10.1161/ATVBAHA.120.314816. Epub 2020 Jul 22.
Abstract
摘要
相似文献
1
Metabolomics, Lipid Pathways, and Blood Pressure Change.代谢组学、脂质代谢途径与血压变化
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1801-1803. doi: 10.1161/ATVBAHA.120.314816. Epub 2020 Jul 22.
2
Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension.人类高血压的代谢组学、脂质组学和药物代谢组学
Adv Exp Med Biol. 2017;956:599-613. doi: 10.1007/5584_2016_79.
3
Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.代谢组学分析揭示了脂质代谢的改变，并确定了一组脂质代谢物作为帕金森病相关焦虑障碍的生物标志物。
Neurosci Lett. 2021 Feb 6;745:135626. doi: 10.1016/j.neulet.2021.135626. Epub 2021 Jan 10.
4
Identification of biomarkers for essential hypertension based on metabolomics.基于代谢组学的原发性高血压生物标志物鉴定。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):382-395. doi: 10.1016/j.numecd.2020.11.023. Epub 2020 Dec 2.
5
[Effects of brown rice on metabolomics related to glucose and lipid in normal rats].糙米对正常大鼠葡萄糖和脂质相关代谢组学的影响
Wei Sheng Yan Jiu. 2021 Jul;50(4):600-608. doi: 10.19813/j.cnki.weishengyanjiu.2021.04.011.
6
Global Plasma Metabolomics to Identify Potential Biomarkers of Blood Pressure Progression.全球血浆代谢组学鉴定血压进展的潜在生物标志物。
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):e227-e237. doi: 10.1161/ATVBAHA.120.314356. Epub 2020 May 28.
7
Comprehensive Metabolomics Study To Assess Longitudinal Biochemical Changes and Potential Early Biomarkers in Nonobese Diabetic Mice That Progress to Diabetes.全面代谢组学研究评估非肥胖型糖尿病小鼠向糖尿病进展过程中的纵向生化变化和潜在的早期生物标志物。
J Proteome Res. 2017 Oct 6;16(10):3873-3890. doi: 10.1021/acs.jproteome.7b00512. Epub 2017 Aug 29.
8
Use of Liquid Chromatography-Mass Spectrometry-Based Metabolomics to Identify Biomarkers of Tuberculosis.基于液相色谱-质谱联用的代谢组学在结核病生物标志物鉴定中的应用
Methods Mol Biol. 2019;1859:241-251. doi: 10.1007/978-1-4939-8757-3_13.
9
Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.脂质组学、生物标志物与精神分裂症：当前视角
Adv Exp Med Biol. 2017;965:265-290. doi: 10.1007/978-3-319-47656-8_11.
10
Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.基于液相色谱-四极杆飞行时间质谱的代谢综合征患者代谢组学特征研究。
Ann Endocrinol (Paris). 2018 Feb;79(1):37-44. doi: 10.1016/j.ando.2017.05.005. Epub 2017 Dec 13.
引用本文的文献
1
Deciphering the Role of Calcium Signaling Pathway-Associated Single Nucleotide Variants in Susceptibility to Hypertension.解读钙信号通路相关单核苷酸变异在高血压易感性中的作用
J Clin Lab Anal. 2025 Feb;39(3):e25141. doi: 10.1002/jcla.25141. Epub 2025 Jan 16.
2
Deletion of altered transcriptomic and metabolomic profiles of Dahl salt-sensitive rats.Dahl盐敏感大鼠转录组和代谢组谱改变的缺失。
iScience. 2024 Sep 12;27(10):110901. doi: 10.1016/j.isci.2024.110901. eCollection 2024 Oct 18.
3
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime.高血压与血脂异常：内皮相关犯罪的两大帮凶。
Curr Atheroscler Rep. 2023 Sep;25(9):605-612. doi: 10.1007/s11883-023-01132-z. Epub 2023 Aug 18.
4
Associations between SNPs, their haplotypes, gene-gene, and gene-environment interactions and dyslipidemia.单核苷酸多态性及其单倍型、基因-基因和基因-环境相互作用与血脂异常的关系。
Aging (Albany NY). 2021 Feb 17;13(4):5906-5927. doi: 10.18632/aging.202514.
本文引用的文献
1
Global Plasma Metabolomics to Identify Potential Biomarkers of Blood Pressure Progression.全球血浆代谢组学鉴定血压进展的潜在生物标志物。
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):e227-e237. doi: 10.1161/ATVBAHA.120.314356. Epub 2020 May 28.
2
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新：来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
3
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 84 种行为、环境和职业以及代谢风险或风险组合的比较风险评估，1990-2016 年：全球疾病负担研究 2016 年的系统分析。
Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8.
4
Essential hypertension: A filtered serum based metabolomics study.原发性高血压：基于过滤血清的代谢组学研究。
Sci Rep. 2017 May 19;7(1):2153. doi: 10.1038/s41598-017-02289-9.
5
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.全球 1990-2015 年高血压和收缩压至少为 110 至 115mmHg 的负担
JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043.
6
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.高血压患病率与控制情况的全球差异：来自90个国家基于人群研究的系统分析
Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912.
7
A Nested Case-Control Study of Association between Metabolome and Hypertension Risk.代谢组与高血压风险关联的巢式病例对照研究。
Biomed Res Int. 2016;2016:7646979. doi: 10.1155/2016/7646979. Epub 2016 Mar 29.
8
Individual variability in human blood metabolites identifies age-related differences.人类血液代谢物的个体差异揭示了与年龄相关的差异。
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4252-9. doi: 10.1073/pnas.1603023113. Epub 2016 Mar 28.
9
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.全基因组关联研究血压极值发现与高血压相关的 UMOD 附近变体。
PLoS Genet. 2010 Oct 28;6(10):e1001177. doi: 10.1371/journal.pgen.1001177.
10
Blood pressure and ageing.血压与衰老
Postgrad Med J. 2007 Feb;83(976):109-14. doi: 10.1136/pgmj.2006.048371.
Zotero 插件